Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging

Journal of Alzheimer's Disease

Volumn 37, Issue 1, 2013, Pages 127-136

  Raven, Erika P ^a   Lu, Po H ^a   Tishler, Todd A ^a   Heydari, Panthea ^a   Bartzokis, George ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Brain Mapping   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; chelation; dementia; ferritin; field dependent relaxation rate increase (FDRI); iron; magnetic resonance imagining (MRI); myelin; prevention; treatment

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; BRAIN TISSUE; CLINICAL ASSESSMENT; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IRON BLOOD LEVEL; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; THALAMUS; TISSUE INJURY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; FERRITINS; HIPPOCAMPUS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84883168593     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130209     Document Type: Article

References (104)

1. Kell DB (2009) Iron behaving badly: Inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomic 2, 2.
2. Altamura S, Muckenthaler MU (2009) Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis 16, 879-895.
3. Castellani RJ, Moreira PI, Perry G, ZhuX(2012) The role of iron as a mediator of oxidative stress in Alzheimer disease. BioFactors 38, 133-138.
4. Ayton S, Lei P, Bush AI (2012) Metallostasis in Alzheimer's disease. Free Radic Biol Med, pii: S0891-5849(12)01800-X. doi: 10.1016/j.freeradbiomed.2012. 10.558.
5. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redoxgenerated free radicals. Proc Natl Acad Sci USA 94, 9866-9868. (Pubitemid 27408156)
6. Bartzokis G (2011) Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging 32, 1341-1371.
7. Bush AI (2013) The metal theory of Alzheimer's disease. J Alzheimers Dis 33, S277-S281.
8. Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ, Huang X, Cahill CM(2008) Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: Riboregulation against neural oxidative damage in Alzheimer's disease. Biochem Soc Trans 36, 1282-1287.
9. Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, Li QX (2002) Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277, 44670-44676. (Pubitemid 36159056)
10. Zou K, Gong JS, Yanagisawa K, Michikawa M (2002) A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J Neurosci 22, 4833-4841. (Pubitemid 37465598)
11. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E,Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867.
12. Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BX, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, McLean CA, Cappai R, Duce JA, Bush AI (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 18, 291-295.
13. Shoji M, Kanai M (2001) Cerebrospinal fluid Abeta40 and Abeta42: Natural course and clinical usefulness. J Alzheimers Dis 3, 313-321. (Pubitemid 32577635)
14. Bartzokis G (2004) Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25, 5-18. (Pubitemid 37522186)
15. Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3, 41-51.
16. Klintworth GK (1973) Huntington's chorea-morphologic contributions of a century. In Advances in Neurology, v.1: Huntington's chorea, 1872-1972, Barbeau A, Paulson GW, Chase TN, eds. Raven Press, New York, pp. 353-368.
17. Hirose W, Ikematsu K, Tsuda R (2003) Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg Med (Tokyo) 5(Suppl 1), S360-S366. (Pubitemid 36537911)
18. Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N, Mintz J (2007) Brain ferritin iron may influence age-and gender-related risks of neurodegeneration. Neurobiol Aging 28, 414-423. (Pubitemid 46177391)
19. Hallgren B, Sourander P (1960) The non-haemin iron in the cerebral cortex in Alzheimer's disease. J Neurochem 5, 307-310.
20. Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM (1992) Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J 287, 509-514.
21. Cornett CR, Markesbery WR, Ehmann WD (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19, 339-345.
22. Connor JR, Menzies SL, St Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31, 75-83.
23. Bartzokis G, Sultzer D, Cummings BJ, Holt LE, Hance DB, Henderson VW, Mintz J (2000) In vivo evaluation of brain iron in Alzheimer's disease and normal controls using magnetic resonance imaging. Arch Gen Psychiatry 57, 47-53. (Pubitemid 30035658)
24. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D,Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R (2002) Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain bank. Alzheimer Dis Assoc Disord 16, 203-212. (Pubitemid 35434796)
25. Raber J, Huang Y, Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25, 641-650. (Pubitemid 38686487)
26. Bartzokis G, Tishler TA, Shin I-S, Lu PH, Cummings JL. (2004) Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases In Redox-active Metals in Neurological Disorders, LeVine S, Connor J, Schipper H, eds. Ann N Y Acad Sci, New York, pp. 224-236. (Pubitemid 38453528)
27. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson's disease: Variation by age, gender, and race/ethnicity. Am J Epidemiol 157, 1015-1022. (Pubitemid 36628805)
28. Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, Booij J, Dluzen DE, Horstink MW (2007) Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 78, 819-824. (Pubitemid 47204585)
29. Wang L, Yang H, Zhao S, Sato H, Konishi Y, Beach TG, AbdelalimEM,Bisem NJ,Tooyama I (2011) Expression and localization of mitochondrial ferritin mRNA in Alzheimer's disease cerebral cortex. PLoS One 6, e22325.
30. Morris CM, Candy JM, Keith AB, Oakley AE, Taylor GA, Pullen RG, Bloxham CA, Gocht A, Edwardson JA (1992) Brain iron homeostasis. J Inorg Biochem 47, 257-265.
31. Floyd RA, Carney JM(1993) The role of metal ions in oxidative processes and aging. Toxicol Ind Health 9, 197-214. (Pubitemid 23216388)
32. Collingwood JF, Chong RK, Kasama T, Cervera-Gontard L, Dunin-Borkowski RE, Perry G, Posfai M, Siedlak SL, Simpson ET, Smith MA, Dobson J (2008) Threedimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis 14, 235-245. (Pubitemid 352040039)
33. Collingwood JF, Mikhaylova A, Davidson M, Batich C, Streit WJ, Terry J, Dobson J (2005) In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis 7, 267-272. (Pubitemid 41206937)
34. Kirschvink JL, Kobayashi-Kirschvink A, Woodford BJ (1992) Magnetite biomineralization in the human brain. Proc Natl Acad Sci USA 89, 7683-7687.
35. Goodman L (1953) Alzheimer's disease: A clinicopathologic analysis of twenty three cases with a theory on pathogenesis. J Nerv Ment Dis 118, 97-130.
36. Bartzokis G, Aravagiri M, Oldendorf WH, Mintz J, Marder SR (1993) Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29, 459-464. (Pubitemid 23112748)
37. Vymazal J, Hajek M, Patronas N, Giedd JN, Bulte JW, Baumgarner C, Tran V, Brooks RA (1995) The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging 5, 554-560.
38. Vymazal J, Brooks RA, Patronas N, Hajek M, Bulte JW, Di Chiro G (1995) Magnetic resonance imaging of brain iron in health and disease. J Neurol Sci 134(Suppl), 19-26.
39. Oldendorf WH, Oldendorf W Jr (1988) Basics of Magnetic Resonance Imaging, Martinus Nijhof Publishing, Boston, MA.
40. Kamman RL, Go KG, Brouwer W, Berendsen HJ (1988) Nuclear magnetic resonance relaxation in experimental brain edema: Effects of water concentration, protein concentration, and temperature. Magn Reson Med 6, 265-274. (Pubitemid 18093951)
41. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J (2003) White matter structural integrity in healthy aging adults and patients with Alzheimer disease: A magnetic resonance imaging study. Arch Neurol 60, 393-398. (Pubitemid 36314365)
42. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings J (2004) Heterogeneous age-related breakdown of white matter structural integrity: Implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 25, 843-851. (Pubitemid 38813164)
43. House MJ, St Pierre TG, McLean C (2008) 1.4T study of proton magnetic relaxation rates, iron concentrations, and plaque burden in Alzheimer's disease and control postmortem brain tissue. Magn Reson Med 60, 41-52. (Pubitemid 351956608)
44. Vymazal J, Brooks RA, Baumgarner C, Tran V, Katz D, Bulte JW, Bauminger R, Di Chiro G (1996) The relation between brain iron and NMR relaxation times: An in vitro study. Magn Reson Med 35, 56-61. (Pubitemid 26017919)
45. Vymazal J, Zak O, Bulte JW, Aisen P, Brooks RA (1996) T1 and T2 of ferritin solutions: Effect of loading factor. Magn Reson Med 36, 61-65. (Pubitemid 26196532)
46. Gossuin Y, Muller RN, Gillis P (2004) Relaxation induced by ferritin:Abetter understanding for an improvedMRI iron quantification. NMR Biomed 17, 427-432. (Pubitemid 39549420)
47. Bulte JW, Miller GF, Vymazal J, Brooks RA, Frank JA (1997) Hepatic hemosiderosis in non-human primates: Quantification of liver iron using different field strengths. Magn Reson Med 37, 530-536. (Pubitemid 27146831)
48. Schenck JF (2003) Magnetic resonance imaging of brain iron. J Neurol Sci 207, 99-102. (Pubitemid 36287110)
49. Kupershmidt L, Amit T, Bar-Am O, Weinreb O, Youdim MB (2012) Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice. Mol Neurobiol 46, 217-220.
50. Fine JM, Baillargeon AM, Renner DB, Hoerster NS, Tokarev J, Colton S, Pelleg A, Andrews A, Sparley KA, Krogh KM, Frey WH, Hanson LR (2012) Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice. Exp Brain Res 219, 381-390.
51. Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J (1999) MRI evaluation of brain iron in earlier-and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 17, 213-222. (Pubitemid 29053180)
52. Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, Huang D, Bordelon Y, Mintz J, Perlman S (2007) Myelin breakdown and iron changes in Huntington's Disease: Pathogenesis and treatment implications. Neurochem Res 32, 1655-1664. (Pubitemid 47428858)
53. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J (1996) Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm 103, 455-490.
54. FolsteinMF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
55. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of theNINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
56. Bartzokis G, Mintz J, Sultzer D, Marx P, Herzberg JS, Phelan CK, Marder SR (1994) In vivoMRevaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 15, 1129-1138. (Pubitemid 24184373)
57. Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR (1997) MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging 15, 29-35. (Pubitemid 27143746)
58. Bartzokis G, Lu PH, Heydari P, Couvrette A, Lee GJ, Kalashyan G, Freeman F, Grinstead JW, Villablanca P, Finn JP, Mintz J, Alger JR, Altshuler LL (2012) Multimodal MRI assessment of white matter aging trajectories over the lifespan of healthy individuals. Biol Psychiatry 72, 1026-1034.
59. Kotzbauer PT, Trojanowsk JQ, Lee VM (2001) Lewy body pathology in Alzheimer's disease. J Mol Neurosci 17, 225-232. (Pubitemid 33063526)
60. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, Lobo A, Martinez-Lage J, Soininen H, Hofman A (2000) Incidence of dementia and major subtypes in Europe: A collaborative study of populationbased cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S10-S15. (Pubitemid 30390599)
61. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A (2000) Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S4-S9. (Pubitemid 30390598)
62. Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study. Ann Neurol 31, 286-292.
63. Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: Possible relation to oxidative stress. J Neurol Sci 143, 137-142. (Pubitemid 26402800)
64. Pankhurst Q, Hautot D, Khan N, Dobson J (2008) Increased levels of magnetic iron compounds in Alzheimer's disease. J Alzheimers Dis 13, 49-52. (Pubitemid 351365627)
65. Besson JA, Best PV, Skinner ER (1992) Post-mortem proton magnetic resonance spectrometric measures of brain regions in patients with a pathological diagnosis of Alzheimer's disease and multi-infarct dementia. Br J Psychiatry 160, 187-190.
66. Bartzokis G, Tishler TA (2000) MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol Biol 46, 821-833.
67. Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, Landfield PW (2003) Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 23, 3807-3819. (Pubitemid 36958487)
68. Kadish I, Thibault O, Blalock EM, Chen KC, Gant JC, Porter NM, Landfield PW (2009) Hippocampal and cognitive aging across the lifespan: A bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment. J Neurosci 29, 1805-1816.
69. Bartzokis G, Lu PH, Tingus K, Peters DG, Amar CP, Tishler TA, Finn JP, Villablanca P, Altshuler LL, Mintz J, Neely E, Connor JR (2011) Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology 36, 1375-1384.
70. Rodrigue KM, Daugherty AM, Haacke EM, Raz N (2013) The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory. Cereb Cortex 23, 1533-1541.
71. Leskovjan AC, Kretlow A, Lanzirotti A, Barrea R, Vogt S, Miller LM (2011) Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease. Neuroimage 55, 32-38.
72. Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW Jr, Cohen ML, Wang X, Siedlak SL, Dwyer BE, Hayashi T, Nakamura M, Nunomura A, Perry G (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis 19, 363-372.
73. Marner L, Nyengaard JR, Tang Y, Pakkenberg B (2003) Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol 462, 144-152. (Pubitemid 36723664)
74. Wyss-Coray T, Rogers J (2012) Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2, a006346.
75. Mueggler T, Pohl H, Baltes C, Riethmacher D, Suter U, Rudin M (2012) MRI signature in a novel mouse model of genetically induced adult oligodendrocyte cell death. Neuroimage 59, 1028-1036.
76. Dyakin VV, Chen Y, Branch CA, Veeranna, Yuan A, Rao M, Kumar A, Peterhoff CM, Nixon RA (2010) The contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models. Neuroimage 51, 1098-1105.
77. Firbank MJ, Blamire AM, Teodorczuk A, Teper E, Mitra D, O'Brien JT (2011) Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies. Psychiatry Res 194, 176-183.
78. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 20, 472-481. (Pubitemid 16005665)
79. Schmued LC, Raymic J, Paule MG, Dumas M, Sarkar S (2013) Characterization of myelin pathology in the hippocampal complex of a transgenic mouse model of Alzheimer's disease. Curr Alzheimer Res 10, 30-37.
80. Benes FM (1989) Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull 15, 585-593. (Pubitemid 20066726)
81. IzawaT,Yamate J, Franklin RJ,KuwamuraM(2010) Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat. Brain Res 1349, 105-114.
82. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: The role of iron. Glia 57, 467-478.
83. Schulz K, Vulpe CD, Harris LZ, David S (2011) Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J Neurosci 31, 13301-13311.
84. Bartzokis G (2012) Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology 62, 2137-2153.
85. Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172, 1053-1061. (Pubitemid 351520001)
86. Schulz K, Kroner A, David S (2012) Iron efflux from astrocytes plays a role in remyelination. J Neurosci 32, 4841-4847.
87. Norkute A, Hieble A, Braun A, Johann S, Clarner T, Baumgartner W, Beyer C, Kipp M (2009) Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J Neurosci Res 87, 1343-1355.
88. Pohl HB, Porcheri C, Mueggler T, Bachmann LC, Martino G, Riethmacher D, Franklin RJ, Rudin M, Suter U (2011) Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci 31, 1069-1080.
89. Franklin RJ,KotterMR(2008) The biology ofCNSremyelination: The key to therapeutic advances. J Neurol 255(Suppl 1), 19-25. (Pubitemid 351341869)
90. Olsson B, Hertze J, Lautner R, Zetterberg H, Nagga K, Hoglund K, Basun H, Annas P, Lannfelt L, Andreasen N, Minthon L, Blennow K, Hansson O (2013) Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia. J Alzheimers Dis 33, 45-53.
91. Schonberg DL, Goldstein EZ, Sahinkaya FR, Wei P, Popovich PG, McTigue DM (2012) Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci 32, 5374-5384.
92. Schonberg DL, McTigue DM (2009) Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol 218, 64-74.
93. Augustinack JC, Helmer K, Huber KE, Kakunoori S, Zollei L, Fischl B (2010) Direct visualization of the perforant pathway in the human brain with ex vivo diffusion tensor imaging. Front Hum Neurosci 4, 42.
94. Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, Avila J, Ferrer I, Arranz R, Patino C (2006) Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 153, 42-54. (Pubitemid 43038614)
95. Lopes KO, Sparks DL, Streit WJ (2008) Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia 56, 1048-1060.
96. Streit WJ, Xue QS (2012) Alzheimer's disease, neuroprotection, and CNS immunosenescence. Front Pharmacol 3, 138.
97. Ding B, Chen KM, LingHW, Sun F, Li X,Wan T, Chai WM, Zhang H, Zhan Y, Guan YJ (2009) Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease. J Magn Reson Imaging 29, 793-798.
98. Lavados M, Guillon M, Mujica MC, Rojo LE, Fuentes P, Maccioni RB (2008) Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. J Alzheimers Dis 13, 225-232. (Pubitemid 352038527)
99. Rajendran R, Minqin R, Ynsa MD, Casadesus G, Smith MA, Perry G, Halliwell B,Watt F (2009) A novel approach to the identification and quantitative elemental analysis of amyloid deposits-insights into the pathology of Alzheimer's disease. Biochem Biophys Res Commun 382, 91-95.
100. Combarros O, Garcia-Roman M, Fontalba A, Fernandez-Luna JL, Llorca J, Infante J, Berciano J (2003) Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord 15, 151-154. (Pubitemid 36206644)
101. Scotland PB, Heath JL, Conway AE, Porter NB, Armstrong MB,Walker JA, Klebig ML, Lavau CP,Wechsler DS (2012) The PICALM protein plays a key role in iron homeostasis and cell proliferation. PLoS One 7, e44252.
102. Tishler TA, Raven EP, Lu PH, Altshuler LL, Bartzokis G (2012) Premenopausal hysterectomy is associated with increased brain ferritin iron. Neurobiol Aging 33, 1950-1958.
103. House MJ, St Pierre TG, Milward EA, Bruce DG, Olynyk JK (2010) Relationship between brain R(2) and liver and serum iron concentrations in elderly men. Magn Reson Med 63, 275-281.
104. Cahill CM, Lahiri DK, Huang X, Rogers JT (2008) Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta 1790, 615-628.